These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33342966

  • 1. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F, Verdoia M, Nardin M, Suryapranata H, Kedhi E, Dudek D, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Atheroscler Thromb; 2021 Feb 01; 28(2):137-145. PubMed ID: 33342966
    [Abstract] [Full Text] [Related]

  • 2. Relationship between adenosine A2a receptor polymorphism rs5751876 and fractional flow reserve during percutaneous coronary intervention.
    Nardin M, Verdoia M, Negro F, Suryapranata H, Khedi E, De Luca G.
    Heart Vessels; 2020 Oct 01; 35(10):1349-1359. PubMed ID: 32367186
    [Abstract] [Full Text] [Related]

  • 3. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
    Verdoia M, Pergolini P, Barbieri L, Rolla R, Nardin M, Negro F, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Thromb Res; 2018 Apr 01; 164():17-23. PubMed ID: 29475177
    [Abstract] [Full Text] [Related]

  • 4. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
    Verdoia M, Schaffer A, Barbieri L, Cassetti E, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Cardiovasc Med (Hagerstown); 2015 Feb 01; 16(2):100-5. PubMed ID: 24625566
    [Abstract] [Full Text] [Related]

  • 5. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Schaffer A, Barbieri L, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Atherosclerosis; 2014 Sep 01; 236(1):169-74. PubMed ID: 25055060
    [Abstract] [Full Text] [Related]

  • 6. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS).
    Platelets; 2014 Sep 01; 25(5):367-72. PubMed ID: 24283589
    [Abstract] [Full Text] [Related]

  • 7. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Marino P, Bellomo G, Sinigaglia F, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Heart Vessels; 2015 Jan 01; 30(1):20-7. PubMed ID: 24297745
    [Abstract] [Full Text] [Related]

  • 8. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini AS, CANARY Investigators.
    JACC Cardiovasc Interv; 2015 Jun 01; 8(7):927-36. PubMed ID: 26003018
    [Abstract] [Full Text] [Related]

  • 9. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
    Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Nutr Metab Cardiovasc Dis; 2014 May 01; 24(5):532-7. PubMed ID: 24418373
    [Abstract] [Full Text] [Related]

  • 10. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G.
    J Thromb Thrombolysis; 2014 Apr 01; 37(3):345-52. PubMed ID: 23793523
    [Abstract] [Full Text] [Related]

  • 11. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y, Chen Z, Ma J, Chen A, Lu D, Wu Y, Ren D, Zhang C, Dai C, Zhang Y, Qian J, Ge J.
    J Cardiol; 2020 Sep 01; 76(3):309-316. PubMed ID: 32354492
    [Abstract] [Full Text] [Related]

  • 12. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2014 May 01; 30(4):297-304. PubMed ID: 24829966
    [Abstract] [Full Text] [Related]

  • 13. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW, Yang HB, Chen YH, Ma JY, Qian JY, Ge JB.
    BMC Cardiovasc Disord; 2017 Feb 27; 17(1):69. PubMed ID: 28241795
    [Abstract] [Full Text] [Related]

  • 14. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, Kandzari DE, Puskas JD, Morice MC, Taggart DP, Leon MB, Lembo NJ, Brown WM, Simonton CA, Dressler O, Kappetein AP, Sabik JF, Serruys PW, Stone GW.
    Eur Heart J; 2019 Jun 21; 40(24):1930-1941. PubMed ID: 30919909
    [Abstract] [Full Text] [Related]

  • 15. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.
    Catheter Cardiovasc Interv; 2015 Mar 21; 85 Suppl 1():762-9. PubMed ID: 25630513
    [Abstract] [Full Text] [Related]

  • 16. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Diabetes Complications; 2015 Mar 21; 29(4):517-22. PubMed ID: 25736187
    [Abstract] [Full Text] [Related]

  • 17. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Nardin M, Bellomo G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2015 Jan 21; 31(1):85-92. PubMed ID: 24898423
    [Abstract] [Full Text] [Related]

  • 18. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.
    Am J Cardiol; 2012 Nov 15; 110(10):1397-404. PubMed ID: 22858186
    [Abstract] [Full Text] [Related]

  • 19. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
    Kang MG, Kang Y, Jang HG, Kim K, Koh JS, Park JR, Hwang SJ, Hwang JY, Bae JS, Ahn JH, Jang JY, Park Y, Jeong YH, Kwak CH, Park HW.
    Coron Artery Dis; 2018 Nov 15; 29(7):589-596. PubMed ID: 29965838
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Ceccon C, Nardin M, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Cardiovasc Revasc Med; 2018 Oct 15; 19(7 Pt A):744-750. PubMed ID: 29656938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.